ASHM is running the Treatment of hepatitis C with Direct Acting Antivirals course at the Rydges Melbourne, Victoria on Saturday, 20 February 2016. This course is being delivered as part of the Control and Elimination within AuStralia of HEpatitis C from people living with HIV (CEASE) project in partnership with the Kirby Institute.
This full day, face-to-face course is designed to up-skill the primary care-based workforce in the current assessment and treatment of HCV infection, to enable rapid scale-up of interferon-free therapy with direct acting antivirals (DAA) for HCV. The course is designed for HIV prescribers, but may also appeal to General Practitioners, Sexual Health Physicians, OST prescribers, clinicians working in AOD settings, custodial settings and Aboriginal Medical Services.
This is a FREE course, which has been approved for 40 Category 1 RACGP points. A small number of travel scholarships for rural and regional medical practitioners to attend may be available upon request.
I have attached a flyer with further details – Feel free to forward to your colleagues and extended networks. To register for this course please go to the courses page on the ASHM website http://www.ashm.org.au/courses.
Please do not hesitate to contact me via return e-mail if you have any queries.
National Policy and Education
ashm | Supporting the HIV, Viral Hepatitis and Sexual Health Workforce
LMB 5057 DARLINGHURST NSW 1300 | www.ashm.org.au -
Monday, 01 February 2016 04:00
ASHM Gearing Up For PBS ListingWritten by Super User
Latest from Super User
- Bioequivalent pharmacokinetics for generic and originator hepatitis C direct-acting antivirals
- Management Of Patients With HCV Who Have Achieved SVR
- Perfectovir - Abbvie Glecaprevir + Pibrentasvir (Maviret) + Sofosbuvir Shines
- Effectiveness of ravidasvir plus sofosbuvir in chronic hepatitis C genotype-4
- How to take the new HCV DAA Medications like Epclusa and Vosevii